Cargando…
Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation
BACKGROUND/OBJECTIVES: Previous research has shown maternal betaine supplementation alleviates fetal-derived hepatic steatosis. Therefore, this study examined the anti-inflammatory effect of maternal betaine intake in offspring mice and its mechanism. MATERIALS/METHODS: Female C57BL/6J mice and thei...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Nutrition Society and the Korean Society of Community Nutrition
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694418/ http://dx.doi.org/10.4162/nrp.2023.17.6.1084 |
_version_ | 1785153372499738624 |
---|---|
author | Li, Lun Sun, Liuqiao Liang, Xiaoping Ou, Qian Tan, Xuying Li, Fangyuan Lai, Zhiwei Ding, Chenghe Chen, Hangjun Yu, Xinxue Wu, Qiongmei Wei, Jun Wu, Feng Wang, Lijun |
author_facet | Li, Lun Sun, Liuqiao Liang, Xiaoping Ou, Qian Tan, Xuying Li, Fangyuan Lai, Zhiwei Ding, Chenghe Chen, Hangjun Yu, Xinxue Wu, Qiongmei Wei, Jun Wu, Feng Wang, Lijun |
author_sort | Li, Lun |
collection | PubMed |
description | BACKGROUND/OBJECTIVES: Previous research has shown maternal betaine supplementation alleviates fetal-derived hepatic steatosis. Therefore, this study examined the anti-inflammatory effect of maternal betaine intake in offspring mice and its mechanism. MATERIALS/METHODS: Female C57BL/6J mice and their offspring were randomly divided into 3 groups according to the treatment received during gestation and lactation: control diet (CD), fatty liver disease (FLD), and fatty liver disease + 1% betaine (FLD-BET). The FLD group was given a high-fat diet and streptozotocin (HFD + STZ), and the FLD-BET group was treated with HFD + STZ + 1% betaine. After weaning, the offspring mice were given a normal diet for 5 weeks and then dissected to measure the relevant indexes. RESULTS: Compared to the CD group, the offspring mice in the FLD group revealed obvious hepatic steatosis and increased serum levels of alanine aminotransferase, interleukin (IL)-6, and tumor necrosis factor (TNF)-α; maternal betaine supplementation reversed these changes. The hepatic mRNA expression levels of IL-6, IL-18, and Caspase-1 were significantly higher in the FLD group than in the CD group. Maternal betaine supplementation reduced the expression of IL-1β, IL-6, IL-18, and apoptosis-associated speck-like protein containing C-terminal caspase recruitment domain (ASC). Maternal betaine supplementation also reversed the increasing protein expressions of nitric oxide dioxygenase-like receptor family pyrin domain containing 3 (NLRP3), ASC, Caspase-1, IL-1β, and IL-18 in offspring mice exposed to HFD + STZ. Maternal betaine supplementation decreased the homocysteine (Hcy) and s-adenosine homocysteine (SAH) levels significantly in the livers. Furthermore, the hepatic Hcy concentrations showed significant inverse relationships with the mRNA expression of TNF-α, NLRP3, ASC, and IL-18. The hepatic SAH concentration was inversely associated with the IL-1β mRNA expression. CONCLUSIONS: The lipotropic and anti-inflammatory effect of maternal betaine supplementation may be associated with the inhibition of NLRP3 inflammasome in the livers of the offspring mice. |
format | Online Article Text |
id | pubmed-10694418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Korean Nutrition Society and the Korean Society of Community Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-106944182023-12-05 Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation Li, Lun Sun, Liuqiao Liang, Xiaoping Ou, Qian Tan, Xuying Li, Fangyuan Lai, Zhiwei Ding, Chenghe Chen, Hangjun Yu, Xinxue Wu, Qiongmei Wei, Jun Wu, Feng Wang, Lijun Nutr Res Pract Original Research BACKGROUND/OBJECTIVES: Previous research has shown maternal betaine supplementation alleviates fetal-derived hepatic steatosis. Therefore, this study examined the anti-inflammatory effect of maternal betaine intake in offspring mice and its mechanism. MATERIALS/METHODS: Female C57BL/6J mice and their offspring were randomly divided into 3 groups according to the treatment received during gestation and lactation: control diet (CD), fatty liver disease (FLD), and fatty liver disease + 1% betaine (FLD-BET). The FLD group was given a high-fat diet and streptozotocin (HFD + STZ), and the FLD-BET group was treated with HFD + STZ + 1% betaine. After weaning, the offspring mice were given a normal diet for 5 weeks and then dissected to measure the relevant indexes. RESULTS: Compared to the CD group, the offspring mice in the FLD group revealed obvious hepatic steatosis and increased serum levels of alanine aminotransferase, interleukin (IL)-6, and tumor necrosis factor (TNF)-α; maternal betaine supplementation reversed these changes. The hepatic mRNA expression levels of IL-6, IL-18, and Caspase-1 were significantly higher in the FLD group than in the CD group. Maternal betaine supplementation reduced the expression of IL-1β, IL-6, IL-18, and apoptosis-associated speck-like protein containing C-terminal caspase recruitment domain (ASC). Maternal betaine supplementation also reversed the increasing protein expressions of nitric oxide dioxygenase-like receptor family pyrin domain containing 3 (NLRP3), ASC, Caspase-1, IL-1β, and IL-18 in offspring mice exposed to HFD + STZ. Maternal betaine supplementation decreased the homocysteine (Hcy) and s-adenosine homocysteine (SAH) levels significantly in the livers. Furthermore, the hepatic Hcy concentrations showed significant inverse relationships with the mRNA expression of TNF-α, NLRP3, ASC, and IL-18. The hepatic SAH concentration was inversely associated with the IL-1β mRNA expression. CONCLUSIONS: The lipotropic and anti-inflammatory effect of maternal betaine supplementation may be associated with the inhibition of NLRP3 inflammasome in the livers of the offspring mice. The Korean Nutrition Society and the Korean Society of Community Nutrition 2023-12 2023-09-19 /pmc/articles/PMC10694418/ http://dx.doi.org/10.4162/nrp.2023.17.6.1084 Text en ©2023 The Korean Nutrition Society and the Korean Society of Community Nutrition https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Li, Lun Sun, Liuqiao Liang, Xiaoping Ou, Qian Tan, Xuying Li, Fangyuan Lai, Zhiwei Ding, Chenghe Chen, Hangjun Yu, Xinxue Wu, Qiongmei Wei, Jun Wu, Feng Wang, Lijun Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation |
title | Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation |
title_full | Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation |
title_fullStr | Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation |
title_full_unstemmed | Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation |
title_short | Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation |
title_sort | maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic nlrp3 inflammasome activation |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694418/ http://dx.doi.org/10.4162/nrp.2023.17.6.1084 |
work_keys_str_mv | AT lilun maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT sunliuqiao maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT liangxiaoping maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT ouqian maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT tanxuying maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT lifangyuan maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT laizhiwei maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT dingchenghe maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT chenhangjun maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT yuxinxue maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT wuqiongmei maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT weijun maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT wufeng maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation AT wanglijun maternalbetainesupplementationamelioratesfattyliverdiseaseinoffspringmicebyinhibitinghepaticnlrp3inflammasomeactivation |